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Abstract 
Problem: The Transfemoral Transcatheter Aortic Valve Replacement (TF TAVR) patient 
transfer workflow in Hospital K's Cardiac Specialty Unit (CSU) is outdated and not aligned with 
current standards employed by other healthcare organizations with TF TAVR programs; for 
example, while many other hospitals discharge TF TAVR patients 24 hours post-procedure, 
Hospital K's discharge process for its TF TAVR patients is is mostly 48hrs or more. By 
following best practices of other healthcare organizations and ensuring no additional 
complications from surgery, Hospital K can reduce its TF TAVR patients' Length of Stay (LOS), 
lower healthcare costs, and avoid complications associated with an extended hospital stay.  
Context: Hospital K is a large, teaching hospital in a highly urbanized region of Northern 
California, one of organization AB's two Bay Area primary cardiac hubs. Hospital K's CSU is a 
32-bedded high-acuity microsystem staffed with highly qualified RNs well trained to care for 
this specific population, typically ranging in age from 55 to 95. The CSU has experienced staff 
who favor improvements in inpatient care. Following the lead of other healthcare organizations, 
Hospital K can develop interdisciplinary teams, standardize its TF TAVR patient-transfer 
workflow and reduce TF TAVR patients' LOS, thereby reducing communication errors between 
microsystems, complications associated with LOS and reduce healthcare costs. Integrating a 
standardized and streamlined clinical pathway to discharge Hospital K's TF TAVR patients 
within 24 hours post-procedure represents an excellent opportunity for the organization's CSU to 
lower healthcare costs without sacrificing patient safety and outcomes.  
Interventions: The main objective of the project is to standardize the workflow for the TF 
TAVR clinical pathway by developing modified screening criteria and streamlined peri- and 
post-procedural guidelines. These new criteria and guidelines will be integrated into the clinical 
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pathway through staff education, enhanced staffing ratio, and a multidisciplinary team approach 
to patient workflow.  
Measures: This project's outcome measure is the number of TF TAVR patients included in the 
clinical pathway discharged within one day following surgery. The number of patients included 
in the pathway but not discharged on a postoperative day one due to atypical complications is the 
balancing measure. This project's process measures are 1) staff engagement with the 
improvement project and 2) revision of the patient-to-nurse staffing ratio from four-to-one to 
three-to-one, which will accommodate the project's higher frequency of clinical assessments per 
patient during the immediate post-procedure period. 
Results: A total of 148 TF TAVR patients qualified for inclusion in the new pathway. Of those, 
84 were discharged postoperative day one. The patients diverted from the new workflow due to 
post-procedure conduction delay, bleeding, and hematoma formation at the femoral access site or 
hemodynamic instability are transferred to the Cardiovascular Intensive Care Unit (CVICU) for a 
higher level of care and observation thus did not discharge per TF TAVR clinical pathway.  
Conclusions: Postprocedure next-day discharge following an uncomplicated TF TAVR 
procedure is feasible by utilizing a minimalist peri-procedure approach, streamlined transfer 
workflow, and a criteria-driven discharge. Organizational protocols, particularly that of the TF 
TAVR workflow, should have input from the multidisciplinary heart team to optimize the 
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Restructuring the Transfer Workflow of Transfemoral Transcatheter Aortic Valve Replacement 
Patients to Optimize Length of Stay: A Clinical Improvement Project in a Microsystem 
Introduction 
The evolution of open-heart surgery, particularly in the aortic-valve replacement 
procedure, has significantly improved in the last decade as it has become more refined and less 
invasive. In August 2019, the Food and Drug Administration (FDA) approved the use of the 
Edwards Sapien 3 heart valve system for low and medium risk aortic stenosis patients. 
According to Edwards Lifesciences (2019), "PARTNER 3 Trial demonstrated that low-risk 
patients treated with the SAPIEN 3 TAVR valve experienced extraordinary outcomes with 1.0 
percent rates of death or disabling stroke at one year, a short length of stay and 96 percent 
discharged to home or self-care". The FDA approval permitted increased use of this heart valve 
device, so heart centers and organizations, particularly Hospital K, have begun using them. In 
keeping with Hospital K's priorities of improving inpatient hospital care and reducing costs. 
Hospital K joined the PARTNER 3 trial. Hospital K has been leading the way in collaborative 
care and plays a vital role in improving customer satisfaction by strengthening its services for 
both new and existing patients; however, despite these improvements to customer services, 
Hospital K's patient workflow process has not evolved to meet current national standards. The 
PARTNER 3 Trial presents an ideal opportunity to study patient workflow processes to identify 
opportunities to create more efficiencies and to meet those national standards of best practices. 
Therefore, this paper will focus on the patient-transfer process within the current workflow for 
TransFemoral Transcatheter Aortic Valve Replacement (TF TAVR) patients to identify critical 
problems that, if resolved, will remarkably improve patient outcomes by optimizing patient 
workflow and minimizing delays in care. To better understand and improve the patient-transfer 
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process, this project incorporates descriptive studies to furnish an up-to-date picture of patient 
workflow and services, includes a microsystem analysis done by unit leaders with upper-
management consultation from Cardiac Service Line leadership for early identification of 
problems within the unit affecting productivity and workgroup outcomes, examines the 
relationship between microsystems in which the TF TAVR workflow occurs and how that 
relationship affects other workplace resources, explores ways to make the TF TAVR program 
more efficient and, finally, develops and tests TF TAVR performance measures. 
Problem Identification 
Organization AB is one of the largest non-profit healthcare organizations in America, 
with 21 hospitals dedicated to serving Northern California. It uses an integrated care model that 
employs more than 100,000 people across the organization, and more than 11,000 physicians 
provide care in its hospitals and clinics. One of these facilities is the cardiac hub for the East Bay 
and the greater San Francisco area. Hospital K is a 239-bedded hospital providing a wide variety 
of procedures, ranging from the invasive, like open-heart Mitral/Aortic/Tricuspid Valve Repair 
or Replacement, to the non-invasive, like the TF TAVR procedures. The core workflow for both 
invasive and non-invasive operations have been remarkably successful in terms of patient 
turnover rate. The facility accommodates three to eight scheduled operations per day, excluding 
emergency procedures, and three to four TF TAVR procedures per week. 
However, the current TF TAVR workflow during the transfer process is outdated. The 
post-procedure care for the TF TAVR population in Hospital K is done via transfer from the 
hybrid Operating Room or Cardiac Catheterization Laboratory to the Cardiovascular Intensive 
Care Unit (CVICU). Most of the TF TAVR patients are given conscious sedation or local 
anesthesia; thus, they do not require ventilator management. That is, this population has no 
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invasive lines (central lines, arterial lines, bladder catheters), which require hemodynamic 
monitoring, so the patients are not on inotropic support at all. After completion of the TF TAVR 
procedure, most can be managed in the post-anesthesia care unit in keeping with the current 
policy and then transferred directly to the medical telemetry floor. Thus, CVICU beds and their 
resources are not overutilized, thereby adding an unnecessary burden to the CVICU team and 
representing an opportunity to create efficiency in the workflow by eliminating the use of these 
beds and their resources. 
Improvements in Hospital K's FastTrack TF TAVR workflow should align with the best 
practices in clinical pathways followed by other facilities using this process. In most hospitals 
that provide the procedure outside organization AB, the median length of stay is only one day for 
early discharge because these facilities have developed standardized procedures driven by a 
minimalist peri-procedural approach, early post-procedure ambulation, reconditioning, and a 
criteria-driven process for patient transfer and discharge. According to Lauck et al. (2016), the 
duration of stay for this patient population is an indicator of exceptional care. This improvement 
project will utilize the model of the 2014 Vancouver 3M (Multidisciplinary, Multimodality, but 
Minimalist) Transcatheter Aortic Valve Replacement Clinical Pathway, which formed an 
expanded heart team drawn from the involved microsystems to standardize the workflow of the 
TF TAVR program. This report states that the Length of Stay and discharge of TF TAVR 
patients depend on multiple factors, including but not limited to 1) eligibility criteria and risk 
stratification as determined by the consensus of a multidisciplinary team, including a nurse 
program coordinator responsible for conducting a comprehensive physical, mental, and social 
functional assessment, and 2) implementing a modified clinical pathway to facilitate a safe 
transfer and early discharge. The standardized workflow for the TF TAVR program will be used 
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to evaluate care and treatment goals in support of evidence-based practices to improve patient 
outcomes while allowing for variations in care, length of stay, and cost of patient care.  
 Available Knowledge 
To support the viability and validity of this improvement project, Hospital K's Financial 
Analyst will extract critical data about the organization's cost reductions from the affected 
clinical microsystems and the quality improvement group. The data for this improvement project 
will be organized and analyzed according to the PICOT question (Population, Intervention, 
Comparison, Outcome, and Time). As a result, this project will investigate among the TF TAVR 
patients (P), how a stratified post-procedure transfer approach (I) compares to a traditional TF 
TAVR transfer pathway (C) and affects the Length of Stay (O) over six months (T). 
An electronic search was conducted in the Cochrane Database of Systemic Reviews, the 
CINAHL Complete, and the Pub Med databases using combinations of the following keywords: 
TF TAVR patients, length of stay, patient screening, discharge process, Post-anesthesia care 
unit, cardiac telemetry care unit, discharge clinical pathway, minimalist approach, post-
procedure care, and cardiac intensive care unit. Search parameters were set to include English 
only research and publication dates no earlier than 2009. The search yielded 153 articles, so the 
Johns Hopkins Nursing Evidence-Based Practice (JHNEBP) research evidence appraisal tool 
was utilized to evaluate the quality of their evidence and to determine the ten most relevant 
studies (see Appendix C for the evaluation table of the studies). From these, three have been 
selected for synthesis to provide the framework for the implementation of evidence-based 
practices to restructure the transfer process of the TF TAVR population. The three most relevant 
studies were Kotronias et al. (2018), Marcantuono et al. (2014), and Lauck et al. (2016). The 
JHNEBP appraisal tool ranked these studies at level IA, level IIIA, and level VA, respectively. 
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These studies concluded that a risk-stratified, non-invasive, minimalist TF TAVR approach is a 
reasonable alternative to the conventional, invasive surgical approach because it presents fewer 
complications to patients without compromising safety and efficacy while supporting the 
hospital cost-reduction program. The evidence explicitly indicates that the best practice for TF 
TAVR patients is to pursue a postoperative one-day standard discharge following 1) a minimalist 
approach, 2) standardized post-procedure care, and 3) criteria-driven discharge.  
Kotronias et al. (2018) conducted a systematic review and meta-analysis, which 
compared the clinical outcomes of TF TAVR patients following the early discharge (ED) 
pathway versus standard discharge. The authors concluded that employing a simplified approach 
as a routine clinical practice for the ED pathway is as safe as standard discharge in terms of 
readmission rates, 30-day mortality, and post-procedure complications requiring permanent 
pacemaker implantation. 
Marcantuono et al. (2014) revealed additional positive impacts of developing a 
standardized clinical pathway to improve outcomes of TF TAVR patients in shortening Length 
of Stay (LOS). The researchers developed a Fast Track Protocol (FTP) for TF TAVR patients 
and established guidelines to enhance their recovery. The nurses then applied these guidelines to 
implement FTP as a clinical pathway for the TF TAVR population. Initiating the FTP enabled 
early recognition of TF TAVR patients who were suitable candidates for FTP, resulting in a 
higher number of qualified candidates than expected. The patients who completed their clinical 
pathway through the FTP shortened their LOS, thereby significantly decreasing hospital costs. 
Lauck et al. (2016) conducted the Vancouver TAVR clinical trial to evaluate a 
standardized clinical pathway for the TF TAVR population and to facilitate a forty-eight-hour 
post-procedure discharge safely. The multidisciplinary TAVR Care Team established protocols 
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to standardize care, to identify a subgroup of patients suitable for early release within the forty-
eight-hour timeframe, and to decrease LOS for all patients. The multidisciplinary Care Team 
utilized risk stratification as eligibility criteria to determine the peri-procedural risk of individual 
patients, and it was guided by standardized post-procedure care protocols and uniform criteria-
driven discharge procedures. The trial concluded that early identification of pre-procedure TF 
TAVR patients who are suitable candidates for FTP is feasible as a method to shorten LOS. 
Rationale 
Implementing clinical change can be particularly challenging because the comfort and 
familiarity of established routines can present barriers. For a planned change to be successful, the 
leadership team must engage staff in improving their practice and involve them in sustaining 
innovations. The most supported method for introducing a planned change involves a purposeful, 
calculated, and collaborative effort (Murphy, 2006). The Nursing and Midwifery Council UK 
(2008) suggested that nurses should deliver care using the best available evidence-based 
practices and that those practices should be continually updated or improved. To introduce 
changes to the TF TAVR transfer process, Lippitt's Phases of Change theory will be used. This 
approach focuses more on the nurse leader's roles and responsibilities as a change agent rather 
than on the change itself (Kritsonis, 2005). To integrate process improvements within the TF 
TAVR transfer process, the nurse leader and affected stakeholders will adhere to Lippitt's seven 
steps: 
1) identifying inefficiencies in the TF TAVR transfer process and making them known to 
staff members of the affected microsystems so that they are aware of the implementation of 
planned change. 
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2) assessing the motivation and capacity of team members within the microsystem to 
execute the planned change and devising a solution to address any barriers that the leadership 
team might encounter. 
3) evaluating the nurse leader's resources and motivations, including the commitment to 
the change, experience in the role, and genuine desire to implement the new transfer process. 
4) selecting a progressive change process, including the development of action plans and 
strategies whereby deadlines are set, and responsibilities are assigned to members of the affected 
microsystems. 
5) identifying the nurse leader's appropriate role and developing a clearly defined 
understanding of that role by all members of the microsystem to prevent confusion and outlining 
each team member's contribution to the TF TAVR transfer process. 
6) maintaining the change by streamlining communications among staff members about 
the progress of their tasks, processing feedback, and holding regular improvement meetings 
among team leaders affected by the planned change to coordinate progress; and lastly 
7) gradually discontinuing the helping relationship of the nurse leader by steadily 
disengaging that person from the role of change agent without disrupting the change and 
undermining the microsystem where the change is made durable by established TF TAVR 
transfer process policies and procedures.  
Executing these seven steps and monitoring their direct results within the microsystem 
are essential responsibilities for the nurse leader in successfully introducing improvements to the 
TF TAVR transfer process. Also, staff dynamics and unit characteristics will significantly impact 
the success of the improvement project. Hospital K's Medical-Telemetry unit and its staff 
members would greatly benefit from the TF TAVR transfer improvement process since it has 
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been successfully implemented among other leading cardiac centers in the country and resulted 
in improved patient outcomes (White, 2004). 
Specific Project Aim 
The specific aim of this project is, by June 30, 2020, to reduce the LOS for elective TF 
TAVR patients from an average of three days to one day post-procedure by implementing a safe, 
evidence-based, standardized, and streamlined transfer workflow and by utilizing a risk-stratified 
clinical pathway to evaluate the care and treatment processes so that the TF TAVR transfer 
workflow improvement project remains sustainable as practices change and levels of care, LOS 
and patient-care costs fluctuate. 
Context 
This improvement project was initiated in a large, teaching hospital in a highly urbanized 
region of Northern California. This facility, Hospital K, is one of organization AB's two Bay 
Area primary cardiac hubs. The main objective of the project is to standardize the transfer 
workflow for TF TAVR patients. An analysis of the Strengths, Weaknesses, Opportunities, and 
Threats (SWOT) of the Cardiac Specialty Unit (CSU) in Hospital K assessed the viability of this 
project (see Appendix D).  Hospital K's Cardiac Specialty Unit is a 32-bedded high-acuity 
microsystem staffed with highly qualified RNs well trained to care for this specific population. 
The typical patient in this high-functioning unit ranges in age from 55 to 95. However, the unit 
also accommodates congenital heart disease patients who can be as young as in their 20s. The 
patients admitted to this unit vary in medical condition but predominantly have heart problems or 
are recovering from open-heart surgery. The CSU has high rates of retention for its RN staff. 
However, they have varying levels of experience; most have served in the unit for over ten years. 
Also, the culture in this unit favorably regards changes to improve inpatient hospital stays. The 
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workflow among team members is cohesive, and every team member in the unit is aware of their 
specific role and of the expectation that they function as part of the multidisciplinary team. The 
high-retention rate, level of experience, attitudes towards improvements in patient care, 
knowledge of roles, and expectations among the members of this team all represent strengths 
favorable to implementing a structured-change process. 
Current patient workflow practices employed by healthcare professionals in the Cardiac 
Specialty Unit (CSU) at Hospital K while transferring patients from one microsystem to another 
are outdated and not focused on patient-centered care. Currently, TF TAVR patients at Hospital 
K move from the operating room to the Intensive-Care Unit for a 24-hour recovery period before 
subsequently moving into the CSU. In contrast, other comparable hospitals transfer patients 
directly from the hybrid CCL to the PACU then to CSU within procedure day. Hospital K's new 
stage of transfer introduces an unnecessary occasion for errors in communications. The Institute 
of Medicine's (IOM) landmark report, To Err is Human: Building a Safer Health System (2000), 
determined that most medical errors have been associated with ineffective communication 
between healthcare microsystems. This description of ineffective communications between 
microsystems matches the environment accommodating TF TAVR patients in Hospital K and 
represents a weakness in the microsystems providing care for them. Since Hospital K's CSU unit 
provides care for the most significant number of patients in the adult services division, its patient 
workflow challenges must be addressed to eliminate longstanding gaps in patient care protocols 
by standardizing the TF TAVR workflow to reduce patients' LOS and to improve their outcomes. 
Since the failure or success of significant improvement projects is often attributed to the 
dynamics of the healthcare professionals working within specific microsystems, empowering 
these frontline professionals with knowledge of the organization's goals and with recognition 
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from management of their important role linking the organization to the customer will enable 
them to achieve their performance goals and targets (Likosky, 2014). This strategy represents an 
opportunity to strengthen Hospital K's communications weakness.  
The microsystems relevant to TF TAVR patients at Hospital K often lack such 
interdisciplinary collaboration, and this weakness threatens Hospital K's standards for patient 
care. The creation of dynamic, interdisciplinary teams among hospital microsystems can improve 
communications among team members and thus improve patient outcomes (Bender, Connelly, 
Brown, 2012). To prevent undesirable results from Hospital K's lack of collaboration, engaging 
in a structured-change process among multidisciplinary teams will provide an opportunity to 
strengthen the weaknesses in collaboration among its microsystems. To ensure safe and efficient 
implementation of a new transfer workflow, budgetary analysis showing how streamlining the 
transfer process will reduce costs and improve the Hospital K's Return on Investment (ROI) has 
been presented to stakeholders. For example, Financial Statistics (FinStat) shows that, from 
January 2020 to June 2020, the average Cost Per Patient Per Day (CPPD) in the CVICU is 
$4,897.30 compared to the CSU's CPPD of $1,805.99—eliminating the CVICU stage of care 
would save each patient $4,897.30. About 100 TF TAVR patients have been included in the new, 
streamlined patient transfer process implemented at Hospital K since January 2020, representing 
a total cost reduction of $489,730.00. Although the cost of training 80 staff nurses over four 
hours at about $100/hour required a $32,000 expenditure, the total cost of integrating the new 
transfer process is still less than the CVICU's annual CPPD and is in compliance with this 
project's focus on patient satisfaction, reduced LOS and cost-saving measures; it thus represents 
a significant value for the stakeholders (see Appendix E for cost-benefit analysis). 
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Intervention 
This improvement project focused on standardizing the TF TAVR workflow in the CSU 
by applying a Plan, Do, Study, Act (PDSA) structure to enable earlier patient recovery, reduced 
LOS, and earlier patient discharge (See Appendix F for the PDSA Cycle). As an improvement 
intervention, nurse leaders and members of the cardiac service line developed a standardized 
transfer workflow to optimize the LOS of the TF TAVR population by: 
Planning: Formulating a patient-specific transfer workflow for Hospital K's CSU staff to 
follow when caring for TF TAVR patients; 
Doing: Using the cardiac service line members, Hospital-Based Practices (HBPs) and the 
nurse leadership team to educate Hospital K's CSU staff on their educational days to develop the 
skill competencies to follow the evidence-based practices utilized by other high performing 
cardiac organizations—on their educational days, participating staff "shadowed" members of the 
CVICU, observed the workflow that they will follow in the CSU unit, and performed a return 
demonstration in the Cardiac Procedural Unit (CPU) regarding the removal of the radial artery 
compression device or TR band with experienced frontline staff to standardize the practice and 
consistently adhere to patient-specific guidelines; 
Studying: soliciting support from Hospital K's administrative leadership to approve an 
enhanced staffing ratio of 3 is to 1 during TF TAVR days and a cut-off time of 2:00 pm for 
accepting patients into the CSU to enable the CSU staff to understand the new workflow and 
present feedback to management on significant observations; 
Acting: Integrating the structured-change improvement procedures within the regular TF 
TAVR patient workflow in Hospital K's CSU. 
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Throughout this improvement project, open communication among affected stakeholders 
was essential for its success. As staff members were re-educated about the new standardized care 
procedures and as the multidisciplinary team incorporated their improved processes into the new 
workflow, ongoing communications were critical for diminishing skepticism and mistrust within 
the system. 
Study of the Intervention 
Hospital K's TF TAVR program in the CSU was generated from multiple evidence-based 
studies presented by the Cardiac Service Line team. For example, the Vancouver Minimalist 
Clinical Care Pathway or 3M TAVR study was adopted as a model for improving the existing 
workflow (see Appendix F for this transfer pathway). The microsystem was assessed in early 
October 2019 to develop a baseline consensus from staff about the new workflow. The workflow 
was presented and discussed during the CSU monthly meeting and daily staffing huddle as a test 
of change. After the frontline staff expressed a definite consensus about the improved workflow, 
broader staff education and further training sessions were carried out in December 2019. Eighty 
percent of CSU staff attended an educational session. With this overwhelming turnout, 
experienced cardiac procedural staff provided a skill simulation regarding groin management, 
TR band removal, TF TAVR patient-specific assessments, and handoff communications between 
HBS, cardiac nurse practitioners, and cardiac procedural interventionists—these communications 
also include the CVICU intensivist regarding any significant change in patient status 
necessitating a higher level of care. Before the 'Go-Live" date of January 2020, the nursing staff 
was encouraged to voice any concerns about the workflow and to provide inputs to improve the 
CSU pathway; these included the patient-to-staff ratio and how to adjust staffing on TF TAVR 
procedure days, especially during the most vulnerable stage of patient recovery. Stakeholders 
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approved an enhanced patient-to-staff ratio of three is to one, cementing the forward movement.  
During the first week of implementation, the process went smoothly, with TF TAVR patients 
undergoing the new transfer workflow. This test case proved to be a significant success for the 
entire cardiac line and staff because the improved process turned out to be reliable and resulted 
in an excellent patient outcome. 
This improvement project was evaluated through clinical audits of patients' Electronic 
Health Records (EHR) on patient outcomes. The action plan was assessed to determine the 
project's reliability and validity. Hospital K's financial analyst and quality improvement team 
generated data via patient charts to validate the success of the improvement project. Monthly 
meetings with stakeholders took place every third Tuesday of the month to provide significant 
input to support the project's sustainability, thus improving staff communications and promoting 
patient safety. Consistent measurements allowed the Clinical Nurse Leader (CNL) to make 
comparisons across the affected microsystems to determine the project's effect on patient 
outcomes. To respond to variables requiring quick attention, the CNL included the frontline staff 
who can readily identify existing barriers to the improvement project. While planned changes are 
vulnerable to failure, careful consideration of the integration of the change theory can streamline 
the process for the CNL and support members of the microsystems so that they will be more 
receptive to it (Mitchell, 2013). 
Measures 
The outcome measure utilized for the project is the percentage of TF TAVR patients who 
over six months, initially met the criteria for inclusion in the TF TAVR pathway and are 
discharged at postoperative day one after undergoing their procedure. The process measure 
would be the following: the percentage of staff who are engaged in the structured-change 
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process, provided with classes and provided with hands-on clinical skills training specifically for 
the TF TAVR pathway; and enhancing the nursing ratio of one nurse for every three patients on 
TF TAVR procedural days, which are Tuesday, Fridays, and every other Thursday. Lastly, the 
percentage of patients that are included in the TF TAVR pathway but did not discharge on a 
postoperative day one would be the balancing measure for this improvement project. The 
Clinical Nurse Leader (CNL) will provide oversight, analysis, and validation of the variables. 
The CNL has the necessary tools to implement this improvement process in keeping with current 
healthcare best practices and standards of care. (See Figure 1 below for the project result). 
Ethical Consideration 
The focus of this study is to improve patient outcomes by revising and updating the 
clinical transfer workflow of the TF TAVR population. Lowering healthcare costs and improving 
patient healthcare outcomes is one of the main objectives for implementing this improvement 
project. There were no ethical implications or conflicts of interest significantly affecting patient 
care delivery when the project was started. This project has been approved as a quality 
improvement project by the University of San Francisco Nursing faculty using Quality 
Improvement Review guidelines. It does not require Institutional Review Board approval. 
 Results 
Since project implementation in January 2020, a total of 148 TF TAVR patients qualified 
for inclusion in the new pathway. Of those, 84 participants were discharged postoperative day 
one (see Appendix H for project improvement tools). According to this measure, the project 
succeeded beyond expectations, considering the massive scope of this project and the difficulties 
of changing nursing practices in a labor-union environment. Initially, CSU staff resisted the 
change, and the California Nurses Association union representative issued a cease-and-desist 
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order demanding that the project not be implemented. However, the CSU Nurse Leaders sought 
staff nurses' input to alleviate their fears and also provided support for the staff, the medical 
team, and other stakeholders to encourage project acceptance and to promote positive changes. 
Chart-audit review revealed a few significant deviations from the new patient workflow 
during the transfer to CSU, including post-procedure conduction delay, bleeding, hematoma 
from the groin access site, and hemodynamic instability, all prompting transfer of the patient to 
the CVICU for a higher level of care and more frequent observation. This group of patients that 
were transferred to CVICU and was deferred from the pathway did not discharge the next day. 
Figure 1: Number of the TF TAVR procedure per month. 40% is the set goal. 
 
Summary 
This quality improvement project has enabled Hospital K to lower healthcare costs 
without sacrificing patient quality outcomes and satisfaction scores. The project addresses 
national patient safety initiatives and goals that focus on process improvements; it also embraces 
all aspects of the Institute of Healthcare Improvement (IHI) Quadruple Aim. The IHI design 
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costs, improving patient outcomes, and ensuring staff satisfaction. Of note, the specific aim of 
this project is to reduce the LOS of TAVR patients from three days to one day postoperatively. 
Currently, TF TAVR interventions have three or four patients allotted for the pathway during 
procedural days; every other Thursday has been added to accommodate an increase in the 
number of mild, moderate, and severe risk aortic stenosis patients utilizing the TF TAVR 
procedure now included in the improved pathway. Also, the 2:00 pm cut-off time has been 
eliminated by hiring an additional HBS team member dedicated to this clinical pathway. 
Nonetheless, continuous evaluation by the leadership team for any significant quality gap within 
the project remains the highest priority.  
In addition, the current COVID 19 pandemic has arisen as a new threat to Hospital K's 
TF TAVR workflow because cardiac patients nationwide are not reporting to emergency rooms 
or seeking care at the same rates as they did before the pandemic impacted hospital care. To 
maximize bed capacity for potential COVID 19 patients, Hospital K had eliminated all non-
COVID-related care; however, in mid-May 2020, Hospital K has resumed receiving non-COVID 
patients. Nevertheless, TF TAVR patients themselves are still avoiding hospital admission for 
fear of acquiring the dreaded virus. The new streamlined patient-transfer procedure, which 
shortens LOS in the Hospital and eliminates care in the CVICU, can mitigate these concerns 
because it removes any exposure to staff and patients in that unit, along with the possibility of 
patient exposure to the virus from that vector. 
Conclusion 
This structured transfer process for the TF TAVR clinical pathway in Hospital K supports 
its goal of providing patient-centered care that utilizes a safe, early patient recovery and 
standardized post-procedure care. However, it is achievable only if affected microsystems 
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support in improving the workflow process to benefit the patient and the organization. 
Specifically, staff engagement in the transfer improvement project is a significant factor in 
determining whether the improved TF TAVR pathway succeeds or fails because, if the staff are 
not fully confident in their ability to provide care for such a heterogeneous group of patients, the 
project will fail even before it launches. The project also fosters progress in the nursing 
profession by investing in knowledge acquisition and skills for practice change and improved 
outcomes. As pat of Hospital K's sustainability project, the leadership team must consistently 
provide clinical support to provide confidence in the affected microsystem staff. To sustain the 
upward traction of the project and maintain its positive output to the organization, staff 
competency must be maintained through training and education initiatives and practice standards 
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Appendix A 
IRB Non-research determination form 
CNL Project: Statement of Non-Research Determination Form 
Student Name: Christina M Mangyao                                                                                                                
 
Title of Project:  
Restructuring the Transfer Workflow of Transfemoral Transcatheter Aortic Valve Replacement 
(TF TAVR) Patients to Optimize Length of Stay 
Brief Description of Project:  
A) Aim Statement:  
  Global Aim: To create and implement a safe, standardized, and streamlined transfer 
workflow for elective TF TAVR patients, thereby enhancing the patient's length of stay to promote 
for next-day discharge 
Specific Aim: The specific aim of this project is, by June 30, 2020, to reduce the LOS for 
elective TF TAVR patients from an average of 3 days to 1 day post-procedure by generating and 
implementing a research-based, safe, standardized, streamlined and restructured transfer workflow.  
B) Description of Intervention: Intervention for the project would be based on a minimalist 
procedure approach, standardized clinical pathway on affected microsystem, and systematic 
discharge criteria to ensure that a safe next-day discharge is achieved. A multidisciplinary team 
safety assessment is included in the pathway to ensure that quality outcomes and goals are met.  
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C) How will this intervention change practice? The intervention would minimize patient 
transfer by eliminating TF TAVR patients from transferring into the Cardiovascular Intensive Care 
Unit (CVICU) post-procedure as the interventional approach is aim towards the minimally 
invasive procedure. A post-procedure stay would be in the Post Anesthesia Care Unit (PACU) to a 
maximum of two hours and post PACU transfer to the Cardiac Specialty Unit within procedure 
day to ensure a safe and positive next-day discharge.  
D) Outcome measurements 
Measures: 
 
Outcome Measures Data Source Target 
Percentage of patients who meet the inclusion 
criteria for the TF TAVR pathway are 
discharged at 24 hours 
Chart documentation 40% 
Process Measures   
Staff engagement for the new process by 
providing classes and hands-on clinical skills 




The nursing staff to patient ratio of 3 is to 1 
during TF TAVR procedural days ( Tuesday, 
Friday, and every other Thursday).  
Staffing 80% 
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Balancing Measures   
Patients included in the clinical pathway but are 
unable to discharge 24hrs post-procedure  





To qualify as an Evidence-based Change in Practice Project, rather than a Research Project, the 
criteria outlined in federal guidelines will be used:  
(http://answers.hhs.gov/ohrp/categories/1569)  
☐   This project meets the guidelines for an Evidence-based Change in Practice Project, as 
outlined in the Project Checklist (attached). The student may proceed with implementation. 
☐This project involves research with human subjects and must be submitted for IRB approval 
before project activity can commence. 
Comments:   
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EVIDENCE-BASED CHANGE OF PRACTICE PROJECT CHECKLIST * 
 
Instructions: Answer YES or NO to each of the following statements: 
Project Title:  
 
YES NO 
The project aims to improve the process or delivery of care with established/ 
accepted standards or to implement evidence-based change. There is no intention 
of using the data for research purposes. 
   
The specific aim is to improve performance on a specific service or program and is 
a part of usual care.  ALL participants will receive a standard of care. 
   
The project is NOT designed to follow a research design, e.g., hypothesis testing 
or group comparison, randomization, control groups, prospective comparison 
groups, cross-sectional, case-control). The project does NOT follow a protocol that 
overrides clinical decision-making. 
   
The project involves the implementation of established and tested quality standards 
and/or systematic monitoring, assessment, or evaluation of the organization to 
ensure that existing quality standards are being met. The project does NOT 
develop paradigms or untested methods or new, untested standards. 
   
The project involves the implementation of care practices and interventions that are 
consensus-based or evidence-based. The project does NOT seek to test an 
intervention that is beyond current science and experience. 
   
The project is conducted by staff where the project will take place and involves 
staff who are working at an agency that has an agreement with USF SONHP. 
   
The project has NO funding from federal agencies or research-focused 
organizations and is not receiving funding for implementation research. 
   
The agency or clinical practice unit agrees that this is a project that will be 
implemented to improve the process or delivery of care, i.e., not a personal 
research project that is dependent upon the voluntary participation of colleagues, 
students, and/ or patients. 
   
If there is an intent to or possibility of publishing your work, you and supervising 
faculty and the agency oversight committee are comfortable with the following 
statement in your methods section: "This project was undertaken as an Evidence-
based change of practice project at X hospital or agency and as such was not 
formally supervised by the Institutional Review Board."  
   
 
ANSWER KEY: If the answer to ALL of these items is yes, the project can be considered an 
Evidence-based activity that does NOT meet the definition of research.  IRB review is not 
required.  Keep a copy of this checklist in your files.  If the answer to ANY of these questions 
is NO, you must submit for IRB approval. 
 
*Adapted with permission of Elizabeth L. Hohmann, MD, Director and Chair, Partners Human 
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Project Charter: Restructuring the Transfer Workflow of Transfemoral Transcatheter Aortic 
Valve Replacement (TF TAVR) Patients to Optimize Length of Stay 
Global Aim:  
To create and implement a patient-specific guideline in the transfer workflow of the TF TAVR 
population, thereby reducing the length of hospital stay. 
Specific Aim:  
By restructuring the transfer process, the TF TAVR patients included in the clinical pathway will 
reduce their length of stay (LOS) from an average of three days to one day by June 30, 2020. 
Background:  
The evolution of open-heart surgery, particularly in aortic valve replacement procedure, has 
significantly improved in the last decade. The method has become more refined and less 
invasive. In August 2019, the Food and Drug Administration (FDA) had approved the use of the 
Edwards Sapien 3 heart valve system for low and medium risk aortic stenosis patients. The 
approval marked a significant improvement in the utilization of the heart valve device. Heart 
centers and organizations, particularly in Hospital K, have begun utilizing such device upgrades. 
However, the current patient workflow process has remained the same and has not evolved into 
the current national standards. This paper will describe the current workflow of TF TAVR 
patients and it will identify critical issues that will remarkably improve patient workflow and 
minimize delays in care. To better understand the transfer process, suggestions have been 
provided such as utilizing descriptive studies to furnish an up-to-date picture of current patient 
workflow and services; microsystem analysis to be done by unit leaders with upper management 
consultation for early identification of unit problem: effects on outcomes, such as productivity 
and workgroup outcomes; examination of the relationship between microsystems where the TF 
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TAVR workflow takes place and other workplace resources; further examination of influences 
on the TF TAVR utilization program; and development and testing of the TF TAVR 
performance measures. This improvement project aims to focus on the role of the Clinical Nurse 
Leader in improving the transfer process of TF TAVR patients from the previous patient transfer 
workflow. Instead, the goal is to integrate a new transfer process that focuses on producing 
positive patient outcomes by reducing inpatient stay, increasing patient and family satisfaction, 
and lowering healthcare costs. The Clinical Nurse Leader (CNL) has the necessary tools to 
implement this improvement process to align with current healthcare practice and standards of 
care. 
Sponsors:  
Bridget Williams, RN, MSN, Chief Nurse Executive 
Judy Kornell, RN, MSN, MBA, CCRN-K, Adult Service Director 
Gilbert Young, RN, MSN-CNL, Nurse Manager 
Lance M Retherford, MD Chief of CardioVascular (CV) Anesthesia 
Lorna Thompson, MD CV Hospital Base Services 
Jacob Mishell, MD Structural Heart Program Director 
Sonja Jung, RN, NP Structural Heart Clinic Director 
Kelsey R Fisher, Financial Analyst 
Kelly McDonnell, Team Lead, Quality Improvement Group 
Team: 
Christina Mangyao, BSN, RN, Assistant Nurse Manager 
Jeanne Ebuen, RN, MSN, Assistant Nurse Manager 
Rheo Rhen Ortega, RN, Assistant Nurse Manager 
RESTRUCTURING THE TRANSFER WORKFLOW 33 
 
Catherine Toscano, BSN, RN, Assistant Nurse Manager 
Cardiac Specialty Unit staff members 
Post-Anesthesia Care Unit staff members 
Goals:  
To provide a standardized and enhanced transfer workflow of elective TF TAVR patients by 
using a streamlined phase of care transfer criteria adjusted to the affected multidisciplinary team 
by:  
1. Modifying the current workflow process and improving communication strategy from affected 
units utilizing the new TF TAVR pathway. 
2. Setting new criteria for patient inclusion and exclusion for the TF TAVR transfer pathway as 
guided by the cardiac medical team and the safety of patient transfer. 
3. Time target inclusion between the transfer process from the Post Anesthesia Care Unit 
(PACU) to the Cardiac Specialty Unit (CSU). 
4. Optimizing clinical measures and guidelines for a safe early discharge for patients approved 
for the TF TAVR pathway from 3 days to a day. 
Measures: 
 
Outcome Measures Data Source Target 
Percentage of patients who meet the inclusion 
criteria for the TF TAVR pathway are 
discharged at 24 hours 
Chart documentation 40% 
Process Measures   
Staff engagement for the new process by 
providing classes and hands-on clinical skills 





The nursing staff to patient ratio of 3 is to 1 
during TF TAVR procedural days ( Tuesday, 
Friday, and every other Thursday).  
Staffing 80% 
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Balancing Measures   
Patients included in the clinical pathway but are 







Background (Global Aim) 
To create and implement a patient-specific guideline in the transfer workflow of TF TAVR 
patients, thereby reducing the length of hospital stay and safe next-day discharge by June 2020 in 
the CSU. 
Population Criteria:  
Elective TF TAVR patients admitted for the clinical pathway from January 2020 to June 2020.  
Data Collection Method:  
Data collection will be obtained through chart documentation via electronic health records 
(EHR) by members of the multidisciplinary team, providing care for this population of patients. 
The baseline sample would be 100 elective TF TAVR patients. The report will include the 
percentage of the patients that satisfactorily transferred to the CSU within the allotted time and is 
safely discharged on a postoperative day one.  
Data Definitions  
 
Data Element Definition 
Audit reports Reports that are generated from data collected 
and reported by affected microsystems. 
TF TAVR pathway  Patients that are included in the enhance 
transfer and discharge process. 
Staff meeting Staff attendance score of 80% and above 
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Transfer Process The process to minimize the length of hospital 
stay by revising the inclusion criteria in the 

























Measure Measure Definition Data source Goal 
Percentage of staff engagement N= total nurse population in 
the CSU. 
D= Total Number of CSU 





Percentage of patients that are included 
in the TF TAVR pathway and discharge 
postoperative day one 
N= Number of TF TAVR 
patients included in the 
pathway 
D=Number of patients 
discharged on postoperative 
day one 
EHR audit  100% 
Percentage of patients that are included 
in the TF TAVR pathway and did not 
discharge postoperative day one 
N= Number of Tf TAVR 
patients included in the 
pathway 
D=Number of patients that 
did not discharge post 
operative day one 
EHR audit   100% 
















The specif aim of 
the project is to 
restructure the 
transfer process, 
thereby TF TAVR 
patients included 
in the clinical 
pathway will 
reduce their length 
of stay (LOS) from 
an average of three 
days to one day by 
June 30, 2020.
Staff Engagement




significant data, and 
process change
Standardized patient 
workflow specific to 
the unit
Measure Outcomes Patient satisfaction 
scores and patient 
care experience, 
patient centered care 
and patient safety
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Changes to test 
 
Hospital K's TF TAVR program in the CSU is generated from the multiple evidence-
based works of literature that were presented by the Cardiac Service Line team. The Vancouver 
Minimalist Clinical Care Pathway or 3M TAVR study was adopted to revised the previous 
workflow (see Appendix1a for the transfer pathway). Microsystem assessment was done in early 
October 2019 to create a baseline consensus from staff on the new workflow. This was presented 
and discussed during the CSU monthly meeting and daily staffing huddle as a test of change. 
After a positive consensus from frontline staff about the improved workflow, staff education and 
training sessions were carried out in December 2019. Eighty percent of CSU staff attended the 
educational session. After an overwhelming staff turnout, skill simulation was provided by 
experienced cardiac procedural staff about groin management, TR band removal, patient 
assessment specific for the TF TAVR patients, and handoff communication workflow between 
HBS, cardiac nurse practitioners, and cardiac procedural interventionalist. The CVICU 
intensivist is also included in the communication loop for any significant change in the patient 
status requiring a higher level of care. Before the 'Go-Live" date of January 2020, staff were 
encouraged to voice any concerns about the workflow and motivated to provide unit inputs that 
can be included in the pathway that is specific for the CSU. Most concerns were staffing ratio 
and how to adjust staffing, especially during the most vulnerable stage of the patient recovery, 
during TF TAVR procedure days. Stakeholders approval for the enhanced patient to staff ratio of 
3 is to 1 cemented the forward movement of the plan change. During the first week of the 
implementation, the process went accordingly with one TF TAVR patient admitted using the 
transfer workflow. It was a significant success for the entire cardiac line and staff that such 
process improvement is reliable and offered an excellent patient outcome.  
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This improvement project was evaluated through clinical audits via patients' Electronic 
Health Records (EHR) on patient outcomes. The effectiveness of the action plan will address the 
reliability and validity of the project. The financial analyst and quality improvement team 
generated data via patient charts to validate the success of the improvement project. Monthly 
meetings with stakeholders are arranged every third Tuesday of the month to provide significant 
input to support the sustainability of the project, thus improving staff communication and 
promote patient safety. Using consistent measurements will allow the Clinical Nurse Leader 
(CNL) to make comparisons across the affected microsystems to determine the effect on patient 
outcomes. To respond to variations that need quick attention and action, the CNL will include 
the frontline staff who can readily identify existing barriers to the improvement project. While 
planned changes are vulnerable to failure, careful consideration of the integration of the change 
theory can streamline the process for the CNL and support members of the microsystems so that 
they will be more receptive to it (Mitchell, 2013). 
CNL Competencies 
 The role of the Clinical Nurse Leader (CNL) in integrating an updated TF TAVR clinical 
pathway at Kaiser Permanente is to lead and implement a collaborative approach within the 
interdisciplinary team. The new integration of care will require the CNL to apply evidence-based 
practices to assess the quality of care delivered by affected microsystems and to lead quality 
improvement processes. The CNL will need to drive and sustain an interdisciplinary approach 
that will ensure the delivery of safe and comprehensive care, efficiently integrate care services 
across multidisciplinary teams, and be cost-effective to the organization. According to Porter-
O'Grady, Clark, and Wiggins (2010), leadership starting at the microsystem is necessary to 
redesign healthcare structures effectively. The CNL must understand the complexities of 
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each microsystem and the work culture of frontline staff. The CNL should possess the 
knowledge and skills to deploy the most useful resources to ensure the best patient outcomes. 
Because the initial costs of integrating the improved patient-transfer process will rise, 
the CNL must also generate support from stakeholders by explaining how the long-term costs 
will decrease and ultimately improve the organization's overall budgetary portfolio. Investing in 
the transformational leadership role of the CNL is an essential factor in implementing 
innovations since the team members feel trust in their leader. Hence, the team members are 
motivated, and they are more aware of the importance of the outcomes in the improvement of 
patient care. (deCasterlé, Willemse, Vershueren, Milisen, 2008). 
Lessons Learned 
 Staff Engagement in the transfer improvement project is a significant factor in 
determining the TF TAVR pathway would be successful or a failure. If the staff are not fully 
confident in their skills to provide care for such a heterogeneous group of patients, the project 
would not take-off even before it starts. The leadership team should consistently provide clinical 
support and have trained superusers to provide confidence to the affected microsystem staff. The 
need for team collaboration among the medical and nursing staff would significantly enhance the 
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Appendix C  
Evaluation Table 
PICOT Question:  In TransFemoral (TF) Transcatheter Aortic Valve Replacement (TAVR) 
patients (P), how does a systematic, post-procedure transfer approach (I), compare to a 
traditional TF TAVR transfer approach (C), affect the length of stay (LOS) (O) over six months 
(T)? 




Kotronias, R. A., Teitelbaum, 
M., Webb, J. G., Mylotte, D., 
Barbanti, M., Wood, D. A., 
Bagur, R. (2018, September 10). 
Early versus standard discharge 
after transcatheter aortic valve 
replacement: A systematic 
review and meta-analysis. 
JACC: Cardiovascular 


















Useful in providing 
relevant data on how 
achievable a one-day 
discharge process is if 
specific benchmarks are 
modified or simplified to 





Lauck, S. B., Wood, D. A., 
Baumbusch, J., Kwon, J., Stub, 
D., Achtem, L., Webb, J. G. 
(2016, April 26). Vancouver 
transcatheter aortic valve 
replacement clinical pathway: 
Minimalist approach 
standardized care and discharge 
criteria to reduced length of 
stay. Circulation: 
Cardiovascular Quality and 











May 2012 and 
October 2014 in 
a heart center in 
Vancouver, 
Canada. 
Early discharge and 
shorter LOS can be 
achieved by implementing 
a pre-procedure risk 
stratification plan, early 
mobilization in post-
procedure care, and 
reconditioning. A 
multidisciplinary team and 
stakeholder 
involvement in adapting 
these advances have 
improved patient 
outcomes and reduced 
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Lauck, S. B., Sathananthan, J., 
Park, J., Achtem, L., Smith, A., 
Keegan, P.,Wood, D. A. (2019, 
November 12). Post-procedure 
protocol to facilitate next-day 
discharge: Results of the 
multidisciplinary multimodality 
but minimalist TAVR 











2015 to 2017 
Implementation of a 
standardized, minimalist 
approach, along with a 
nurse-lead post-procedural 
protocol, has resulted in a 
safe and optimal next-day 
discharge with a lower 30 
days readmission risk. 
Level V 
A 
Marcantuono, R., Gutsche, J., 
Burke-Julien, M., Anwaruddin, 
S., Augoustides, J. G., Jones, D., 
Herrmann, H. C. (2014, 
November 20). Rationale 
development implementation 
and initial results of a fast track 
protocol for transfemoral 
transcatheter aortic valve 
replacement. Catheterization 
and Cardiovascular 
























Patients who completed 
the FT pathway 
experienced a shorter LOS 
and fewer direct costs as 
compared to those who 
deviated or were ineligible 
for the pathway. 
Level III 
A 
Rathore, S., Latyshev, Y., 
Emore, S., Rowe, J., & Foerst, J. 
(2017, December). Safety 
predictors of next-day discharge 
after elective transfemoral 
transcatheter aortic valve 
replacement. Cardiovascular 
Revascularization 












at heart institute 
in Roanoke, VA 
The development of a fast 
track protocol has been 
described to reduce LOS 
and decrease overall 
procedure cost. Next-day 
discharge is safe and 
achievable in 
uncomplicated elective TF 
TAVR. If procedural 
changes and a minimalist 
approach is implemented 
to simplify care, then next 
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Chopra, M., Luk, N. H., Backer, 
O. D., & Sondergaard, L. (2018, 
December 10). Simplification 
and optimization of transcatheter 
aortic valve implantation- fast 
track course without 
compromising safety and 
efficacy. BMC Cardiovascular 




Case Report None Adopting a minimalist 
procedure and optimizing 
care to decrease LOS have 
shown a marked 
advantage over the 
traditional approach 
without compromising 






























TF TAVR Cost-Benefit Analysis from January 2020 to June 2020 between CVICU 
admission and CSU admission: 
 
Source: FinStat 
Total TF TAVR  
Cases in 6 Months 
  CVICU CPPD 
  $4,897.30 
  CSU CPPD 








Staff Training and Education Days:  
80 CSU staff x $100/hr (including overtime hours) x 4 hours Education/Training: 
 =$32,000 total 
 
 
Return of Investment Calculation:  
CPPD days in CVICU- CPPD from utilizing CSU bed - Cost of Training: 
Net Savings: = $901,103.20-$332,302.16-$32,000 
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Appendix F  
PDSA Cycle 
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Appendix G 
Process Map of the TF TAVR Transfer Workflow 
 
 




Figure 1: Number of the TF TAVR procedure. The discharge goal for POD #1 is set at 40%. 
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Six Months Discharge Trend of TF TAVR 
following Clinical Pathway
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